Sign in

CIK 0001497253

  • Non-accelerated filer
  • Smaller reporting company

VivoSim Labs, INC.

Sign in to watch
Ticker
VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
271488943
Phone
+1 858-224-1000
Business address
11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
Former names
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
Open-market buys, last 90 days
$2,804
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lialin Tony Serge +$3K Chief Commercial Officer 1 filing

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-07-11 Bush Jennifer General Counsel & Secretary Grant or award +50,000 50,000
2016-07-11 Bush Jennifer General Counsel & Secretary Grant or award · Stock Option (Right to Buy) +100,000 100,000
2016-02-16 Murphy Keith Chairman, CEO and President Shares withheld for taxes −24,690 $2.04 $50K 5,919,638
2016-02-16 Murphy Keith Chairman, CEO and President Grant or award · Stock Option (Right to Buy) +24,690 24,690
2015-09-21 Baltera Robert Jr. Director Sale −6,000 $4.03 $24K 138,506
2015-08-24 MICHAELS BARRY D Chief Financial Officer Shares withheld for taxes −100,692 $2.32 $234K 86,808
2015-08-24 MICHAELS BARRY D Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,692 100,692
2015-08-20 Malloy Kirk Director Grant or award · Stock Option (Right to Buy) +37,000 37,000
2015-08-20 HOWSON TAMAR D Director Grant or award · Stock Option (Right to Buy) +37,000 37,000
2015-08-20 Heyman Richard A. Director Grant or award · Stock Option (Right to Buy) +37,000 37,000
2015-08-20 GLOVER JAMES T Director Grant or award · Stock Option (Right to Buy) +37,000 37,000
2015-08-20 Baltera Robert Jr. Director Grant or award · Stock Option (Right to Buy) +37,000 37,000
2015-08-20 Gallant Paul General Manager Grant or award · Stock Option (Right to Buy) +225,000 225,000
2015-08-13 GLOVER JAMES T Director Purchase +10,000 $2.80 $28K 10,000
2015-08-12 Murphy Keith Chairman, CEO and President Purchase +20,000 $2.56 $51K 5,944,328
2015-06-04 Renard Michael EVP of Commercial Operations Grant or award · Stock Option (Right to Buy) +130,000 130,000
2015-06-04 Presnell Sharon Collins EVP, Research & Dev & CTO Grant or award · Stock Option (Right to Buy) +130,000 130,000
2015-06-04 Murphy Keith Chairman, CEO and President Grant or award · Stock Option (Right to Buy) +465,000 465,000
2015-06-04 MICHAELS BARRY D Chief Financial Officer Grant or award · Stock Option (Right to Buy) +255,000 255,000
2015-06-04 David Eric CSO & EVP Pre-Clinical Dev Grant or award · Stock Option (Rignt to Buy) +130,000 130,000

Page 12 of 13 · 259 trades